CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: D-penicillamine
Accession: CHEBI:7959
browse the term
Definition: An optically active form of penicillamine having D-configuration. Pharmaceutical form (L-form is toxic) of chelating agent used to treat heavy metal poisoning.
Synonyms: exact_synonym: (2S)-2-amino-3-methyl-3-sulfanylbutanoic acid; 3-sulfanyl-D-valine
related_synonym: (S)-2-amino-3-mercapto-3-methylbutanoic acid; (S)-3,3-dimethylcysteine; 3-mercapto-D-valine; Cuprimine; D-Penamine; D-beta,beta-dimethylcysteine; Depen; Formula=C5H11NO2S; InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8)/t3-/m0/s1; InChIKey=VVNCNSJFMMFHPL-VKHMYHEASA-N; PA; SMILES=CC(C)(S)[C@@H](N)C(O)=O; penicilamina; penicillamine; penicillaminum
alt_id: CHEBI:469179
xref: Beilstein:1722375; CAS:52-67-5; DrugBank:DB00859; Drug_Central:2081; HMDB:HMDB0014997; KEGG:C07418; KEGG:D00496
xref_mesh: MESH:D010396
xref: PDBeChem:LEI; PMID:10408968; PMID:13793949; PMID:16736232; PMID:1709917; PMID:18570451; PMID:19904729; PMID:21989991; PMID:22076732; PMID:22151785; PMID:22169274; PMID:22683336; PMID:23200399; PMID:23342748; PMID:23375251; PMID:2420897; PMID:7196231; Reaxys:1722375; Wikipedia:Penicillamine
cyclic_relationship: is_enantiomer_of CHEBI:50869
G
Ace2
angiotensin converting enzyme 2
increases expression
ISO
Penicillamine results in increased expression of ACE2 mRNA
CTD
PMID:32808185
NCBI chr X:30,293,597...30,340,961
Ensembl chr X:30,293,589...30,340,977
G
Ahcy
adenosylhomocysteinase
increases activity multiple interactions
ISO
Penicillamine results in increased activity of AHCY protein Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of AHCY protein]
CTD
PMID:22945834
NCBI chr 3:143,569,134...143,584,359
Ensembl chr 3:143,569,094...143,584,393
G
Alox12
arachidonate 12-lipoxygenase, 12S type
increases expression decreases expression
EXP
Penicillamine results in increased expression of ALOX12 mRNA Penicillamine results in decreased expression of ALOX12 mRNA
CTD
PMID:19575532
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
G
Alox5ap
arachidonate 5-lipoxygenase activating protein
increases expression
EXP
Penicillamine results in increased expression of ALOX5AP mRNA
CTD
PMID:19575532
NCBI chr12:5,748,941...5,772,986
Ensembl chr12:5,748,944...5,772,986
G
Anxa1
annexin A1
decreases expression increases expression
EXP
Penicillamine results in decreased expression of ANXA1 mRNA Penicillamine results in increased expression of ANXA1 mRNA
CTD
PMID:19575532
NCBI chr 1:217,861,175...217,877,205
Ensembl chr 1:217,861,175...217,877,343
G
Anxa4
annexin A4
increases expression decreases expression
EXP
Penicillamine results in increased expression of ANXA4 mRNA Penicillamine results in decreased expression of ANXA4 mRNA
CTD
PMID:19575532
NCBI chr 4:119,184,378...119,241,183
Ensembl chr 4:119,184,374...119,241,161
G
App
amyloid beta precursor protein
multiple interactions increases metabolic processing
ISO
Penicillamine inhibits the reaction [[[[APP protein modified form binds to Copper] which co-treated with Ascorbic Acid] results in increased oxidation of Phosphatidylcholines] which results in increased chemical synthesis of phosphatidylcholine hydroperoxide]; Penicillamine inhibits the reaction [APP protein results in increased activity of CASP3 protein] Penicillamine results in increased metabolism of APP protein
CTD
PMID:10940226 PMID:12963085 PMID:17964426
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
G
Atf6
activating transcription factor 6
multiple interactions
ISO
Penicillamine results in increased metabolism of and results in increased activity of ATF6 protein
CTD
PMID:19722195
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
G
Atp7a
ATPase copper transporting alpha
multiple interactions
ISO
[Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7A protein]
CTD
PMID:21242307
NCBI chr X:71,094,144...71,201,550
Ensembl chr X:71,094,202...71,198,354
G
Atp7b
ATPase copper transporting beta
multiple interactions
ISO
[Penicillamine co-treated with ATP7B gene mutant form] results in decreased activity of CAT protein; [Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7B protein]; Penicillamine inhibits the reaction [ATP7B gene mutant form results in decreased abundance of Copper]; Penicillamine inhibits the reaction [ATP7B gene mutant form results in decreased abundance of Glutathione]; Penicillamine inhibits the reaction [ATP7B gene mutant form results in decreased expression of CP protein] Penicillamine inhibits the reaction [ATP7B protein mutant form results in increased abundance of Copper]; Penicillamine inhibits the reaction [ATP7B protein mutant form results in increased expression of TNF mRNA]; Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of AHCY protein]; Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of CPT1A protein]; Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of DNMT3B mRNA]; Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of HSPA5 protein]; Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of PPARA mRNA]; Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of SREBF1 mRNA]
CTD
PMID:21242307 PMID:22945834 PMID:24368744
NCBI chr16:69,952,286...70,024,404
Ensembl chr16:69,951,778...70,023,636
G
Bbc3
Bcl-2 binding component 3
decreases expression
ISO
Penicillamine results in decreased expression of BBC3 protein
CTD
PMID:22843330
NCBI chr 1:77,013,281...77,022,509
Ensembl chr 1:77,014,543...77,022,509
G
Bcl2
BCL2, apoptosis regulator
decreases expression
ISO
Penicillamine results in decreased expression of BCL2 mRNA; Penicillamine results in decreased expression of BCL2 protein
CTD
PMID:22843330
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Bid
BH3 interacting domain death agonist
multiple interactions
EXP
andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]]; Penicillamine inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]]
CTD
PMID:20946909
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
G
C1s
complement C1s
multiple interactions
ISO
Penicillamine inhibits the reaction [C4A protein binds to C1S protein]; Penicillamine inhibits the reaction [C4B protein binds to C1S protein]
CTD
PMID:8435078
NCBI chr 4:157,430,249...157,442,438
Ensembl chr 4:157,430,117...157,442,303
G
C3
complement C3
increases expression
EXP
Penicillamine results in increased expression of C3 mRNA
CTD
PMID:19575532
NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
G
C4a
complement C4A
multiple interactions
ISO
Penicillamine inhibits the reaction [C4A protein binds to C1S protein]
CTD
PMID:8435078
NCBI chr20:4,005,731...4,020,083
Ensembl chr20:4,005,731...4,020,080
G
C4b
complement C4B
multiple interactions
ISO
Penicillamine inhibits the reaction [C4B protein binds to C1S protein]
CTD
PMID:8435078
NCBI chr20:4,197,371...4,211,684
Ensembl chr20:4,197,366...4,211,681
G
Casp3
caspase 3
multiple interactions increases cleavage
EXP ISO
andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]]; Penicillamine inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased cleavage of CASP3 protein]] Penicillamine inhibits the reaction [APP protein results in increased activity of CASP3 protein] Penicillamine results in increased cleavage of CASP3 protein
CTD
PMID:12963085 PMID:19722195 PMID:20946909 PMID:22843330
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
EXP
andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]]; Penicillamine inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]; Penicillamine promotes the reaction [andrographolide inhibits the reaction [Copper Sulfate results in increased activity of CASP9 protein]]
CTD
PMID:20946909
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
decreases expression multiple interactions
ISO
Penicillamine results in decreased expression of CAT mRNA [Penicillamine co-treated with ATP7B gene mutant form] results in decreased activity of CAT protein
CTD
PMID:22843330 PMID:24368744
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Ccl3
C-C motif chemokine ligand 3
increases expression
ISO
Penicillamine results in increased expression of CCL3 mRNA
CTD
PMID:22843330
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
G
Ccl4
C-C motif chemokine ligand 4
increases expression
ISO EXP
Penicillamine results in increased expression of CCL4 mRNA
CTD
PMID:19575532 PMID:22843330
NCBI chr10:68,466,394...68,468,229
Ensembl chr10:68,452,052...68,468,231
G
Ccl5
C-C motif chemokine ligand 5
increases expression
EXP
Penicillamine results in increased expression of CCL5 mRNA
CTD
PMID:19575532
NCBI chr10:68,322,826...68,327,380
Ensembl chr10:68,322,829...68,327,377
G
Ccr5
C-C motif chemokine receptor 5
increases expression decreases expression
EXP
Penicillamine results in increased expression of CCR5 mRNA Penicillamine results in decreased expression of CCR5 mRNA
CTD
PMID:19575532
NCBI chr 8:123,752,423...123,757,538
Ensembl chr 8:123,752,325...123,759,260
G
Cd14
CD14 molecule
decreases expression increases expression
EXP
Penicillamine results in decreased expression of CD14 mRNA Penicillamine results in increased expression of CD14 mRNA
CTD
PMID:19575532
NCBI chr18:28,335,522...28,337,383
Ensembl chr18:28,335,340...28,337,261
G
Cd163
CD163 molecule
decreases expression increases expression
EXP
Penicillamine results in decreased expression of CD163 mRNA Penicillamine results in increased expression of CD163 mRNA
CTD
PMID:19575532
NCBI chr 4:157,085,080...157,118,470
Ensembl chr 4:157,085,093...157,117,878
G
Cd38
CD38 molecule
increases expression
EXP
Penicillamine results in increased expression of CD38 mRNA
CTD
PMID:19575532
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
G
Cd52
CD52 molecule
decreases expression
EXP
Penicillamine results in decreased expression of CD52 mRNA
CTD
PMID:19575532
NCBI chr 5:146,319,789...146,321,348
Ensembl chr 5:146,319,969...146,321,348
G
Clu
clusterin
multiple interactions
ISO
[Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7A protein]; [Penicillamine co-treated with bathocuproine sulfonate] promotes the reaction [CLU protein binds to ATP7B protein]
CTD
PMID:21242307
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Cp
ceruloplasmin
decreases expression multiple interactions
ISO
Penicillamine results in decreased expression of CP protein Penicillamine inhibits the reaction [ATP7B gene mutant form results in decreased expression of CP protein]
CTD
PMID:24013775 PMID:24368744
NCBI chr 2:102,439,433...102,498,075
Ensembl chr 2:102,439,624...102,498,075
G
Cpt1a
carnitine palmitoyltransferase 1A
decreases expression multiple interactions
EXP ISO
Penicillamine results in decreased expression of CPT1A mRNA Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of CPT1A protein]
CTD
PMID:19575532 PMID:22945834
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
G
Crp
C-reactive protein
decreases expression
ISO
Penicillamine results in decreased expression of CRP protein
CTD
PMID:241598
NCBI chr13:85,135,384...85,175,178
Ensembl chr13:85,124,977...85,175,178
G
Csf2
colony stimulating factor 2
increases expression
EXP
Penicillamine results in increased expression of CSF2 mRNA
CTD
PMID:19575532
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
G
Cxcr4
C-X-C motif chemokine receptor 4
increases expression decreases expression
EXP
Penicillamine results in increased expression of CXCR4 mRNA Penicillamine results in decreased expression of CXCR4 mRNA
CTD
PMID:19575532
NCBI chr13:40,077,976...40,081,883
Ensembl chr13:40,077,976...40,081,883
G
Cyp1a1
cytochrome P450, family 1, subfamily a, polypeptide 1
increases expression
ISO
Penicillamine results in increased expression of CYP1A1 mRNA
CTD
PMID:22843330
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
G
Cyp2e1
cytochrome P450, family 2, subfamily e, polypeptide 1
increases expression
ISO
Penicillamine results in increased expression of CYP2E1 mRNA
CTD
PMID:22843330
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Penicillamine results in increased expression of DDIT3 mRNA; Penicillamine results in increased expression of DDIT3 protein
CTD
PMID:19722195 PMID:22843330
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
G
Dnmt3a
DNA methyltransferase 3 alpha
decreases expression
ISO
Penicillamine results in decreased expression of DNMT3A mRNA
CTD
PMID:22945834
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
G
Dnmt3b
DNA methyltransferase 3 beta
multiple interactions
ISO
Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of DNMT3B mRNA]
CTD
PMID:22945834
NCBI chr 3:142,130,588...142,169,128
Ensembl chr 3:142,130,592...142,169,124
G
Dusp1
dual specificity phosphatase 1
decreases expression
EXP
Penicillamine results in decreased expression of DUSP1 mRNA
CTD
PMID:19575532
NCBI chr10:16,680,478...16,683,275
G
Dusp6
dual specificity phosphatase 6
increases expression
EXP
Penicillamine results in increased expression of DUSP6 mRNA
CTD
PMID:19575532
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
G
Egr1
early growth response 1
increases expression
EXP ISO
Penicillamine results in increased expression of EGR1 mRNA
CTD
PMID:19575532 PMID:22843330
NCBI chr18:26,462,967...26,466,766
Ensembl chr18:26,462,981...26,466,766
G
Eif2ak3
eukaryotic translation initiation factor 2 alpha kinase 3
multiple interactions
ISO
Penicillamine results in increased phosphorylation of and results in increased activity of EIF2AK3 protein
CTD
PMID:22843330
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
G
Eif2s1
eukaryotic translation initiation factor 2 subunit alpha
increases phosphorylation
ISO
Penicillamine results in increased phosphorylation of EIF2S1 protein
CTD
PMID:22843330
NCBI chr 6:97,672,829...97,697,499
Ensembl chr 6:97,672,766...97,706,225
G
Eln
elastin
affects localization
ISO
Penicillamine affects the localization of ELN protein
CTD
PMID:3954958
NCBI chr12:21,968,544...22,011,929
Ensembl chr12:21,968,544...22,011,928
G
Fcnb
ficolin B
increases expression
EXP
Penicillamine results in increased expression of FCNB mRNA
CTD
PMID:19575532
NCBI chr 3:11,393,713...11,402,198
Ensembl chr 3:11,393,739...11,402,151
G
Fmo1
flavin containing dimethylaniline monoxygenase 1
increases expression
ISO
Penicillamine results in increased expression of FMO1 mRNA
CTD
PMID:22843330
NCBI chr13:75,182,184...75,214,439
Ensembl chr13:75,182,176...75,214,647
G
Fmo5
flavin containing dimethylaniline monoxygenase 5
increases expression
ISO
Penicillamine results in increased expression of FMO5 mRNA
CTD
PMID:22843330
NCBI chr 2:185,197,184...185,249,699
Ensembl chr 2:185,222,204...185,249,693
G
Fn1
fibronectin 1
increases expression
EXP
Penicillamine results in increased expression of FN1 mRNA
CTD
PMID:19575532
NCBI chr 9:73,196,044...73,264,695
Ensembl chr 9:73,196,044...73,264,678
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
increases expression
ISO
Penicillamine results in increased expression of GADD45A mRNA
CTD
PMID:22843330
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
G
Gatm
glycine amidinotransferase
increases expression
EXP
Penicillamine results in increased expression of GATM mRNA
CTD
PMID:19575532
NCBI chr 3:109,658,919...109,675,508
Ensembl chr 3:109,658,951...109,684,129
G
Gstm5
glutathione S-transferase, mu 5
increases expression
ISO
Penicillamine results in increased expression of GSTM3 mRNA
CTD
PMID:22843330
NCBI chr 2:195,531,599...195,534,562
Ensembl chr 2:195,531,495...195,534,553
G
Hmox1
heme oxygenase 1
multiple interactions decreases expression increases expression
ISO
[Penicillamine co-treated with bathocuproine sulfonate] results in increased expression of HMOX1 protein Penicillamine analog results in decreased expression of HMOX1 protein Penicillamine results in increased expression of HMOX1 mRNA
CTD
PMID:19323979 PMID:21242307 PMID:22843330
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
G
Hp
haptoglobin
decreases expression
ISO
Penicillamine results in decreased expression of HP protein
CTD
PMID:241598
NCBI chr19:37,539,626...37,544,178
Ensembl chr19:37,539,627...37,544,523
G
Hspa1a
heat shock protein family A (Hsp70) member 1A
increases expression
ISO
Penicillamine results in increased expression of HSPA1A mRNA; Penicillamine results in increased expression of HSPA1A protein
CTD
PMID:22843330
NCBI chr20:3,870,765...3,873,221
Ensembl chr20:3,856,006...3,873,227
G
Hspa1l
heat shock protein family A (Hsp70) member 1 like
increases expression
ISO
Penicillamine results in increased expression of HSPA1L mRNA
CTD
PMID:22843330
NCBI chr20:3,848,843...3,855,571
Ensembl chr20:3,848,843...3,855,571
G
Hspa2
heat shock protein family A (Hsp70) member 2
increases expression
ISO
Penicillamine results in increased expression of HSPA2 mRNA
CTD
PMID:22843330
NCBI chr 6:95,128,504...95,131,281
Ensembl chr 6:95,128,350...95,131,287
G
Hspa5
heat shock protein family A (Hsp70) member 5
increases expression multiple interactions
ISO
Penicillamine results in increased expression of HSPA5 protein Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of HSPA5 protein]
CTD
PMID:19722195 PMID:22843330 PMID:22945834
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
G
Hspa6l-ps1
heat shock protein family A (Hsp70) member 6 like, pseudogene 1
increases expression
ISO
Penicillamine results in increased expression of HSPA6 mRNA
CTD
PMID:22843330
NCBI chr13:83,273,176...83,274,317
G
Ifng
interferon gamma
increases expression
EXP
Penicillamine results in increased expression of IFNG mRNA
CTD
PMID:19575532
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
G
Igf1
insulin-like growth factor 1
multiple interactions
ISO
Penicillamine inhibits the reaction [IGF1 protein results in increased activity of MTR protein]
CTD
PMID:14745455
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
G
Il10
interleukin 10
increases expression
EXP
Penicillamine results in increased expression of IL10 mRNA
CTD
PMID:19575532
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
G
Il13
interleukin 13
decreases expression increases expression
EXP
Penicillamine results in decreased expression of IL13 mRNA Penicillamine results in increased expression of IL13 mRNA
CTD
PMID:19575532
NCBI chr10:37,790,130...37,792,687
Ensembl chr10:37,790,130...37,792,737
G
Il15
interleukin 15
increases expression
EXP
Penicillamine results in increased expression of IL15 mRNA
CTD
PMID:19575532
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
G
Il1b
interleukin 1 beta
increases expression
EXP
Penicillamine results in increased expression of IL1B mRNA
CTD
PMID:19575532
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il21
interleukin 21
increases expression
EXP
Penicillamine results in increased expression of IL21 mRNA
CTD
PMID:21227906
NCBI chr 2:120,117,105...120,127,012
Ensembl chr 2:120,119,444...120,126,996
G
Il23a
interleukin 23 subunit alpha
increases expression
ISO
Penicillamine results in increased expression of IL23A protein
CTD
PMID:19575532
NCBI chr 7:721,809...723,923
Ensembl chr 7:721,809...723,923
G
Il3ra
interleukin 3 receptor subunit alpha
increases expression
EXP
Penicillamine results in increased expression of IL3RA mRNA
CTD
PMID:19575532
NCBI chr12:16,318,081...16,323,781
Ensembl chr12:16,318,081...16,323,484
G
Il4
interleukin 4
increases expression
EXP
Penicillamine results in increased expression of IL4 mRNA
CTD
PMID:9182889 PMID:21227906
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
G
Il6
interleukin 6
increases expression
EXP ISO
Penicillamine results in increased expression of IL6 protein
CTD
PMID:19575532 PMID:21227906
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Klf4
KLF transcription factor 4
increases expression
EXP
Penicillamine results in increased expression of KLF4 mRNA
CTD
PMID:19575532
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
G
Lgals1
galectin 1
increases expression
EXP
Penicillamine results in increased expression of LGALS1 mRNA
CTD
PMID:19575532
NCBI chr 7:110,485,239...110,488,345
Ensembl chr 7:110,481,392...110,488,345
G
Loxl2
lysyl oxidase-like 2
decreases activity
ISO
Penicillamine results in decreased activity of LOXL2 protein
CTD
PMID:16023247
NCBI chr15:44,683,449...44,773,067
Ensembl chr15:44,683,880...44,773,067
G
Mcl1
MCL1 apoptosis regulator, BCL2 family member
multiple interactions decreases expression
ISO
PMAIP1 mutant form inhibits the reaction [Penicillamine results in decreased expression of MCL1 protein]
CTD
PMID:22843330
NCBI chr 2:183,219,137...183,235,676
Ensembl chr 2:183,219,220...183,222,303
G
Mpo
myeloperoxidase
decreases secretion multiple interactions
ISO
Penicillamine results in decreased secretion of MPO protein Penicillamine promotes the reaction [[MPO protein results in increased oxidation of dibromoacetonitrile] which results in increased chemical synthesis of Cyanides]; Penicillamine promotes the reaction [MPO protein results in increased oxidation of dibromoacetonitrile]
CTD
PMID:6324512 PMID:25614581
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
G
Mtr
5-methyltetrahydrofolate-homocysteine methyltransferase
multiple interactions
ISO
Penicillamine inhibits the reaction [IGF1 protein results in increased activity of MTR protein]
CTD
PMID:14745455
NCBI chr17:58,219,998...58,308,560
Ensembl chr17:58,220,071...58,304,822
G
Nfe2l2
NFE2 like bZIP transcription factor 2
increases expression
EXP
Penicillamine results in increased expression of NFE2L2 mRNA
CTD
PMID:19575532
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nos2
nitric oxide synthase 2
increases expression
ISO
Penicillamine results in increased expression of NOS2 mRNA
CTD
PMID:22843330
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nr4a1
nuclear receptor subfamily 4, group A, member 1
increases expression
EXP
Penicillamine results in increased expression of NR4A1 mRNA
CTD
PMID:19575532
NCBI chr 7:132,368,399...132,389,300
Ensembl chr 7:132,374,840...132,389,297
G
Parp1
poly (ADP-ribose) polymerase 1
increases cleavage
ISO
Penicillamine results in increased cleavage of PARP1 protein
CTD
PMID:22843330
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Pmaip1
phorbol-12-myristate-13-acetate-induced protein 1
increases expression multiple interactions
ISO
Penicillamine results in increased expression of PMAIP1 mRNA; Penicillamine results in increased expression of PMAIP1 protein PMAIP1 mutant form inhibits the reaction [Penicillamine results in decreased expression of MCL1 protein]
CTD
PMID:22843330
NCBI chr18:59,986,020...59,992,434
Ensembl chr18:59,986,017...59,992,429
G
Ppara
peroxisome proliferator activated receptor alpha
multiple interactions
ISO
Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of PPARA mRNA]
CTD
PMID:22945834
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
G
Prl
prolactin
multiple interactions increases expression
ISO
Danazol inhibits the reaction [Penicillamine results in increased expression of PRL]
CTD
PMID:4087275
NCBI chr17:37,859,999...37,870,062
Ensembl chr17:37,860,007...37,870,062
G
Ptger2
prostaglandin E receptor 2
increases expression
EXP
Penicillamine results in increased expression of PTGER2 mRNA
CTD
PMID:19575532
NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
G
Ptgs1
prostaglandin-endoperoxide synthase 1
increases expression
ISO
Penicillamine results in increased expression of PTGS1 mRNA
CTD
PMID:22843330
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
G
RT1-CE16
RT1 class I, locus CE16
affects response to substance
ISO
HLA-A gene polymorphism affects the susceptibility to Penicillamine
CTD
PMID:3459889
NCBI chr20:3,257,109...3,260,747
Ensembl chr20:3,257,123...3,279,563
G
RT1-Db1
RT1 class II, locus Db1
increases response to substance
ISO
HLA-DRB1 gene polymorphism results in increased susceptibility to Penicillamine
CTD
PMID:6420562
NCBI chr20:4,548,664...4,558,237
Ensembl chr20:4,548,666...4,558,258
G
S100a4
S100 calcium-binding protein A4
increases expression
EXP
Penicillamine results in increased expression of S100A4 mRNA
CTD
PMID:19575532
NCBI chr 2:176,090,951...176,093,258
Ensembl chr 2:176,091,804...176,093,254
G
S100a6
S100 calcium binding protein A6
increases expression
EXP
Penicillamine results in increased expression of S100A6 mRNA
CTD
PMID:19575532
NCBI chr 2:176,100,619...176,102,181
Ensembl chr 2:176,100,899...176,102,180
G
S100a8
S100 calcium binding protein A8
decreases expression increases expression
EXP
Penicillamine results in decreased expression of S100A8 mRNA Penicillamine results in increased expression of S100A8 mRNA
CTD
PMID:19575532
NCBI chr 2:176,166,517...176,167,645
Ensembl chr 2:176,167,124...176,167,643
G
S100a9
S100 calcium binding protein A9
decreases expression increases expression
EXP
Penicillamine results in decreased expression of S100A9 mRNA Penicillamine results in increased expression of S100A9 mRNA
CTD
PMID:19575532
NCBI chr 2:176,190,361...176,193,182
Ensembl chr 2:176,190,361...176,193,230
G
Selenbp1
selenium binding protein 1
decreases expression
EXP
Penicillamine results in decreased expression of SELENBP1 mRNA
CTD
PMID:19575532
NCBI chr 2:182,494,004...182,504,594
Ensembl chr 2:182,493,978...182,504,594
G
Slc11a1
solute carrier family 11 member 1
increases expression
EXP
Penicillamine results in increased expression of SLC11A1 mRNA
CTD
PMID:19575532
NCBI chr 9:75,957,193...75,968,115
Ensembl chr 9:75,957,316...75,968,101
G
Slc28a2
solute carrier family 28 member 2
decreases expression increases expression
EXP
Penicillamine results in decreased expression of SLC28A2 mRNA Penicillamine results in increased expression of SLC28A2 mRNA
CTD
PMID:19575532
NCBI chr 3:109,324,815...109,387,702
Ensembl chr 3:109,366,996...109,387,702
G
Slc30a1
solute carrier family 30 member 1
decreases expression increases expression
EXP
Penicillamine results in decreased expression of SLC30A1 mRNA Penicillamine results in increased expression of SLC30A1 mRNA
CTD
PMID:19575532
NCBI chr13:103,491,037...103,494,910
Ensembl chr13:103,491,037...103,494,910
G
Slc31a1
solute carrier family 31 member 1
multiple interactions increases expression
ISO
[Penicillamine results in increased expression of SLC31A1 mRNA] which results in decreased susceptibility to Oxaliplatin; [Penicillamine results in increased expression of SLC31A1 mRNA] which results in increased susceptibility to Carboplatin; [Penicillamine results in increased expression of SLC31A1 mRNA] which results in increased susceptibility to Cisplatin; Cisplatin promotes the reaction [Penicillamine results in increased expression of SLC31A1 mRNA]; Penicillamine promotes the reaction [Cisplatin results in increased expression of SLC31A1 mRNA]
CTD
PMID:22914438
NCBI chr 5:75,814,744...75,844,241
Ensembl chr 5:75,814,743...75,844,228
G
Slc4a1
solute carrier family 4 member 1 (Diego blood group)
decreases expression
EXP
Penicillamine results in decreased expression of SLC4A1 mRNA
CTD
PMID:19575532
NCBI chr10:87,306,865...87,323,132
Ensembl chr10:87,306,872...87,323,117
G
Sod1
superoxide dismutase 1
decreases activity
ISO
Penicillamine analog results in decreased activity of SOD1 protein
CTD
PMID:19323979
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
G
Sp1
Sp1 transcription factor
increases expression
ISO
Penicillamine results in increased expression of SP1 mRNA
CTD
PMID:22914438
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
G
Srebf1
sterol regulatory element binding transcription factor 1
multiple interactions
ISO
Penicillamine promotes the reaction [ATP7B protein mutant form results in decreased expression of SREBF1 mRNA]
CTD
PMID:22945834
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
G
Stx3
syntaxin 3
increases expression decreases expression
EXP
Penicillamine results in increased expression of STX3 mRNA Penicillamine results in decreased expression of STX3 mRNA
CTD
PMID:19575532
NCBI chr 1:208,617,018...208,686,240
Ensembl chr 1:208,639,115...208,685,805
G
Tfrc
transferrin receptor
increases expression
EXP
Penicillamine results in increased expression of TFRC mRNA
CTD
PMID:19575532
NCBI chr11:68,163,413...68,185,257
Ensembl chr11:68,163,413...68,185,257
G
Tnf
tumor necrosis factor
increases expression multiple interactions
ISO
Penicillamine results in increased expression of TNF protein Penicillamine inhibits the reaction [ATP7B protein mutant form results in increased expression of TNF mRNA]
CTD
PMID:19575532 PMID:22945834
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
increases expression decreases expression
ISO
Penicillamine results in increased expression of TP53 protein Penicillamine results in decreased expression of TP53 mRNA
CTD
PMID:22843330
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
G
Xbp1
X-box binding protein 1
increases splicing
ISO
Penicillamine results in increased splicing of XBP1 mRNA
CTD
PMID:19722195
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all